Fingerprint
Dive into the research topics of 'Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
S. M A Kazmi, R. M. Saliba, M. Donato, M. Wang, C. Hosing, S. Qureshi, P. Anderlini, U. Popat, R. E. Champlin, S. A. Giralt, M. H. Qazilbash
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations